Literature DB >> 15047555

Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.

Ziya Cibali Acikgoz1, Ebru Almayanlar, Sohret Gamberzade, Safiye Gocer.   

Abstract

Macrolide resistance in 156 consecutive group B streptococcal isolates was investigated. Thirty-five isolates (22.4%) had inducible (80%) or constitutive (20%) erythromycin resistance. The genes responsible were erm(B), erm(A) subclass erm(TR), and erm(B) plus erm(TR) in 62.9, 2.9, and 8.6% of isolates, respectively. Nine isolates (25.7%) harbored neither mef nor detectable erm genes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15047555      PMCID： PMC375322          DOI： 10.1128/AAC.48.4.1410-1412.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain.

Authors:  A Portillo; M Lantero; I Olarte; F Ruiz-Larrea; C Torres
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

2.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002.

Authors:  Alper Ergin; Serpil Ercis; Gülsen Hasçelik
Journal:  Int J Antimicrob Agents       Date:  2003-08       Impact factor: 5.283

4.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.

Authors:  Brigitte Malbruny; Kensuke Nagai; Maëlle Coquemont; Bülent Bozdogan; Arjana Tambic Andrasevic; Helena Hupkova; Roland Leclercq; Peter C Appelbaum
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

6.  High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.

Authors:  J I Alós; B Aracil; J Oteo; C Torres; J L Gómez-Garcés
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

7.  Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

Authors:  E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.

Authors:  Esther Culebras; Iciar Rodriguez-Avial; Carmen Betriu; Montserrat Redondo; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  High incidence of erythromycin-resistant streptococci in Taiwan.

Authors:  J J Wu; K Y Lin; P R Hsueh; J W Liu; H I Pan; S M Sheu
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

10.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191
View more
  5 in total

1.  Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay.

Authors:  Xianyu Zeng; Fanrong Kong; Hui Wang; Archie Darbar; Gwendolyn L Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

Authors:  M A De Francesco; S Caracciolo; F Gargiulo; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-26       Impact factor: 3.267

3.  High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae Strains Isolated from Clinical Samples in Tehran, Iran.

Authors:  Mohammad Emaneini; Akbar Mirsalehian; Reza Beigvierdi; Abbas Ali Imani Fooladi; Fatemeh Asadi; Fereshteh Jabalameli; Morovat Taherikalani
Journal:  Maedica (Buchar)       Date:  2014-06

4.  Survey of strain distribution and antibiotic resistance pattern of group B streptococci (Streptococcus agalactiae) isolated from clinical specimens.

Authors:  Seyed Masoud Mousavi; Mona Nasaj; Seyed Mostafa Hosseini; Mohammad Reza Arabestani
Journal:  GMS Hyg Infect Control       Date:  2016-09-12

5.  Rapid determination of macrolide and lincosamide resistance in group B streptococcus isolated from vaginal-rectal swabs.

Authors:  Wilfred P Dela Cruz; Joann Y Richardson; Judith M Broestler; Jennifer A Thornton; Patrick J Danaher
Journal:  Infect Dis Obstet Gynecol       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.